Completed NA INTERVENTIONAL 1-arm NCT05829499

PMCF Study to Evaluate Performance and Safety of Xanoftal Next

Interventional, Non-comparative, Single-center PMCF Study to Evaluate Performance and Safety of Xanoftal Next Used to Attenuate Symptoms of Seasonal Allergic Conjunctivitis, Even When Associated With Dry Eye Syndrome

Sponsor: C.O.C. Farmaceutici S.r.l.

Conditions Allergic Conjunctivitis Dry Eye Dry Eye Disease

Interventions HPMC-HA eyedrops

Updated 4 times since 2023 Last updated: May 3, 2023 Started: Dec 2, 2022 Primary completion: Feb 6, 2023 Completion: Feb 6, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Allergic Conjunctivitis and Dry Eye, this trial is completed. The trial is conducted by C.O.C. Farmaceutici S.r.l. and has accumulated 4 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2023 — Jul 2024 [monthly]

Completed NA
May 2023 — Jun 2023 [monthly]

Completed NA

First recorded

Dec 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

C.O.C. Farmaceutici S.r.l.

Data source: C.O.C. Farmaceutici S.r.l.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catanzaro, Italy